Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals.

Cerebral white matter lesions (WMLs) are considered a reflection of cerebral and systemic small vessel disease (SVD), and are associated with reductions in brain volume. Like the brain, the kidney is also sensitive to factors that affect vasculature. Glomerular dysfunction due to renal vascular damage can be measured with different biochemical parameters, such as creatinine or cystatin C, although cystatin C is considered to be more accurate than creatinine in the elderly. The purpose of the study was to determine whether manifestations of SVD in the kidney can predict SVD-based damage to the brain. We examined the relationship between glomerular dysfunction as a measure of SVD on WMLs, gray matter (GM) volume, and cognition in 735 cognitively normal participants from the Cardiovascular Health Study Cognition Study. The multivariate analyses controlled for demographic characteristics, hypertension, heart disease, diabetes, Apolipoprotein 4 allele, C reactive protein, lipids, physical activity, smoking, and body mass index (BMI). Elevated cystatin C levels were associated with lower neuropsychological test scores, the presence of MRI-identified brain infarcts, the severity of WMLs, and GM atrophy five years later. In adjusted models, GM volume was significantly associated with cystatin-C only until BMI and severity of WMLs were added to the model, meaning that the effect of SVD on GM volume is mediated by these two variables. These findings suggest that age-related SVD is a process that leads to altered brain structure, and creates a vulnerability state for cognitive decline.

[1]  Oscar L. Lopez,et al.  Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[2]  Henri A. Vrooman,et al.  Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.

[3]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[4]  A Hofman,et al.  C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.

[5]  Michael W. Weiner,et al.  A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly , 2010, Proceedings of the National Academy of Sciences.

[6]  S. Seliger,et al.  Lessons about brain vascular disease from another pulsating organ, the kidney. , 2008, Stroke.

[7]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[8]  Owen Carmichael,et al.  White matter lesions and brain gray matter volume in cognitively normal elders , 2012, Neurobiology of Aging.

[9]  John Breitner,et al.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. , 2003, Archives of neurology.

[10]  Michael W Weiner,et al.  Longitudinal MRI and cognitive change in healthy elderly. , 2007, Neuropsychology.

[11]  Paige E. Scalf,et al.  Aerobic exercise training increases brain volume in aging humans. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  Teri,et al.  A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. , 1994, AJNR. American journal of neuroradiology.

[13]  Peter J. Gianaros,et al.  Higher blood pressure predicts lower regional grey matter volume: Consequences on short-term information processing , 2006, NeuroImage.

[14]  B. Kestenbaum,et al.  Cystatin C and aging success. , 2008, Archives of internal medicine.

[15]  M. Sarnak,et al.  Association of cystatin C with adverse outcomes , 2009, Current opinion in nephrology and hypertension.

[16]  G. Mitchell Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. , 2008, Journal of applied physiology.

[17]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[18]  Lewis H Kuller,et al.  Incidence and Prevalence of Dementia in the Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.

[19]  A Hofman,et al.  Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.

[20]  A. Hofman,et al.  Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. , 2000, Stroke.

[21]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[22]  E Auffray,et al.  Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.

[23]  Hideo Hara,et al.  Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults , 2010, Hypertension Research.

[24]  A. Toga,et al.  Brain Structure and Obesity , 2009, NeuroImage.

[25]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[26]  P. Wolf,et al.  Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. , 2007, Current Alzheimer research.

[27]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[28]  C. Rosano,et al.  Cystatin C as a marker of cognitive function in elders: Findings from the health ABC study , 2008, Annals of neurology.

[29]  A. Benton Abbreviated versions of the Visual Retention Test. , 1972, The Journal of psychology.

[30]  T. Manolio,et al.  Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : the Cardiovascular Health Study. CHS Collaborative Research Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Anne Newman,et al.  Cystatin C and subclinical brain infarction. , 2005, Journal of the American Society of Nephrology : JASN.

[32]  Sudha Seshadri,et al.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. , 2009, JAMA.

[33]  Nick Bryan,et al.  Clinical Correlates of Ventricular and Sulcal Size on Cranial Magnetic Resonance Imaging of 3,301 Elderly People , 1999, Neuroepidemiology.

[34]  Oscar L. Lopez,et al.  Evaluation of Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[35]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[36]  W. Janssens,et al.  Serum Cystatin C Concentration Compared with Other Markers of Glomerular Filtration Rate in the Old Old , 2002, Journal of the American Geriatrics Society.

[37]  A. Hofman,et al.  Periventricular cerebral white matter lesions predict rate of cognitive decline , 2002, Annals of neurology.

[38]  Alan C. Evans,et al.  Enhancement of MR Images Using Registration for Signal Averaging , 1998, Journal of Computer Assisted Tomography.

[39]  S. Studenski,et al.  Gait Variability Is Associated with Subclinical Brain Vascular Abnormalities in High-Functioning Older Adults , 2007, Neuroepidemiology.

[40]  C. Jack,et al.  Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships , 2008, Journal of the Neurological Sciences.

[41]  S. Cummings,et al.  Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. , 2005, Journal of the American Society of Nephrology : JASN.

[42]  Xiaohua Chen,et al.  Gray matter reduction is correlated with white matter hyperintensity volume: A voxel-based morphometric study in a large epidemiological sample , 2006, NeuroImage.

[43]  Norman J Beauchamp,et al.  Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2005, Stroke.

[44]  Kewei Chen,et al.  Brain abnormalities in human obesity: A voxel-based morphometric study , 2006, NeuroImage.

[45]  V. Gudnason,et al.  Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study. , 2011, Brain : a journal of neurology.

[46]  T. Kawanami,et al.  Cystatin C as an index of cerebral small vessel disease: results of a cross‐sectional study in community‐based Japanese elderly , 2010, European journal of neurology.

[47]  L. Fried,et al.  Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. , 1998, Stroke.

[48]  C. Björkelund,et al.  A 24-year follow-up of body mass index and cerebral atrophy , 2004, Neurology.

[49]  D. Siscovick,et al.  Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.

[50]  M. Caldwell,et al.  American Heart Association: Council on Cardiovascular Nursing , 2004, The Journal of cardiovascular nursing.

[51]  A. Benton Contributions to Neuropsychological Assessment: A Clinical Manual , 1983 .

[52]  Masaki Mogi,et al.  Clinical Interaction between Brain and Kidney in Small Vessel Disease , 2011, Cardiology research and practice.

[53]  Hiroshi Fukuda,et al.  Relationship Between Body Mass Index and Gray Matter Volume in 1,428 Healthy Individuals , 2008, Obesity.

[54]  E P Steinberg,et al.  Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. , 1994, Stroke.

[55]  Ralph B. D’Agostino,et al.  Obesity, diabetes and cognitive deficit: The Framingham Heart Study , 2005, Neurobiology of Aging.

[56]  P. J. Koudstaal,et al.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI , 2003, Diabetologia.